**Core Concept**
Guillain-Barre Syndrome (GBS) is an autoimmune disorder characterized by the rapid onset of muscle weakness and paralysis due to demyelination of the peripheral nerves. This demyelination leads to impaired nerve conduction, resulting in ascending muscle weakness.

**Why the Correct Answer is Right**
GBS typically follows a recent infection, such as Campylobacter jejuni, which triggers an immune response against the peripheral nerves. The autoantibodies produced in this response target the myelin sheath of the nerves, leading to demyelination and conduction block. The most common presentation of GBS is ascending weakness, which may progress to respiratory failure. The treatment of GBS involves supportive care, including mechanical ventilation, and intravenous immunoglobulin (IVIG) or plasmapheresis to reduce autoantibody levels.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because GBS is indeed characterized by the presence of anti-ganglioside antibodies, particularly anti-GM1 and anti-GD1a antibodies, which target the myelin sheath of the peripheral nerves.

**Option B:** Incorrect because the typical presentation of GBS is indeed ascending weakness, which may progress to involve the cranial nerves and respiratory muscles.

**Option C:** Incorrect because GBS is indeed associated with a history of recent infection, particularly Campylobacter jejuni, which triggers the autoimmune response against the peripheral nerves.

**Option D:** Incorrect because the correct answer is not provided.

**Clinical Pearl / High-Yield Fact**
GBS is a medical emergency that requires prompt recognition and treatment to prevent long-term neurological damage. The Miller Fisher variant of GBS is characterized by the presence of ophthalmoplegia, ataxia, and areflexia, and is associated with a poorer prognosis.

**Correct Answer:** D